INTRALIPID 20% Drug Patent Profile
✉ Email this page to a colleague
When do Intralipid 20% patents expire, and when can generic versions of Intralipid 20% launch?
Intralipid 20% is a drug marketed by Fresenius and is included in two NDAs.
The generic ingredient in INTRALIPID 20% is soybean oil. There are thirteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the soybean oil profile page.
Summary for INTRALIPID 20%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 3 |
| Clinical Trials: | 83 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | INTRALIPID 20% at DailyMed |
Recent Clinical Trials for INTRALIPID 20%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Yale University | Phase 1 |
| University of Kansas Medical Center | Early Phase 1 |
| Assiut University | N/A |
Pharmacology for INTRALIPID 20%
| Drug Class | Lipid Emulsion |
Anatomical Therapeutic Chemical (ATC) Classes for INTRALIPID 20%
US Patents and Regulatory Information for INTRALIPID 20%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fresenius | INTRALIPID 20% | soybean oil | INJECTABLE;INJECTION | 018449-001 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Fresenius | INTRALIPID 20% | soybean oil | INJECTABLE;INJECTION | 020248-001 | Aug 7, 1996 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
